Hyam Levitsky
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Biomedical Engineering, Radiology, ImmunologyGoogle:
"Hyam Levitsky"Parents
Sign in to add mentor| Drew M. Pardoll | post-doc | Johns Hopkins Medical School (Cell Biology Tree) |
Children
Sign in to add trainee| Dileep D. Monie | research assistant | Johns Hopkins Medical School (Neurotree) | |
| Kevin F. Staveley-O'Carroll | grad student | 2000 | Johns Hopkins |
| Zhengbin Lu | grad student | 2001 | Johns Hopkins |
| Gladys G. Tan | grad student | 2005 | Johns Hopkins |
| Paria Mirmonsef | grad student | 2007 | Johns Hopkins |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Minn I, Huss DJ, Ahn HH, et al. (2019) Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Science Advances. 5: eaaw5096 |
| Hoves S, Ooi CH, Wolter C, et al. (2018) Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity. The Journal of Experimental Medicine |
| Fu H, Wang J, Fu J, et al. (2016) Tumor Antigen Vaccination of Donors to Augment Graft-Versus-Tumor Effects after Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Blood. 128: 499-499 |
| Kadayakkara DK, Korrer MJ, Bulte JW, et al. (2015) Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging. Cancer Research. 75: 51-61 |
| Cannarile M, Hoves S, Broeske A, et al. (2015) Abstract PR04: Targeting tumor-asoociated macrophages with a novel anti-CSF1R antibody in cancer patients Cancer Research. 75 |
| Agarwal M, Saint-Fleur A, Fu J, et al. (2015) Abstract 4048: HPV16 immunity induced by immune responses to mutations in E6 and E7 proteins Cancer Research. 75: 4048-4048 |
| Fu H, Fu J, Wang J, et al. (2015) Abstract 1351: Post-transplantation cyclophosphamide depletes vaccine primed donor T cells and compromises graft-versus-tumor effects in alloBMT model Immunology. 75: 1351-1351 |
| Prince G, Thoburn C, Warlick E, et al. (2015) 55 IN VIVO OLIGOCLONAL T-CELL EXPANSION AND SPECIFIC IN VITRO T-CELL RESPONSES FOLLOWING K562/GM-CSF VACCINATION OF MDS PATIENTS Leukemia Research. 39: S26 |
| Ries CH, Cannarile MA, Hoves S, et al. (2014) Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 25: 846-59 |
| Marabelle A, Kohrt H, Sagiv-Barfi I, et al. (2013) Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. The Journal of Clinical Investigation. 123: 2447-63 |